Literature DB >> 17767352

Regulation of immune cells by eicosanoid receptors.

Nancy Kim1, Andrew D Luster.   

Abstract

Eicosanoids are potent, bioactive, lipid mediators that regulate important components of the immune response, including defense against infection, ischemia, and injury, as well as instigating and perpetuating autoimmune and inflammatory conditions. Although these lipids have numerous effects on diverse cell types and organs, a greater understanding of their specific effects on key players of the immune system has been gained in recent years through the characterization of individual eicosanoid receptors, the identification and development of specific receptor agonists and inhibitors, and the generation of mice genetically deficient in various eicosanoid receptors. In this review, we will focus on the receptors for prostaglandin D2, DP1 and DP2/CRTH2; the receptors for leukotriene B4, BLT1 and BLT2; and the receptors for the cysteinyl leukotrienes, CysLT1 and CysLT2, by examining their specific effects on leukocyte subpopulations, and how they may act in concert towards the development of immune and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767352      PMCID: PMC5900949          DOI: 10.1100/tsw.2007.181

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  23 in total

Review 1.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

2.  12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels.

Authors:  Amanda R Hajek; Alexa R Lindley; Silvio Favoreto; Roderick Carter; Robert P Schleimer; Douglas A Kuperman
Journal:  J Allergy Clin Immunol       Date:  2008-08-09       Impact factor: 10.793

3.  Cytosolic Phospholipase A2α Is Essential for Renal Dysfunction and End-Organ Damage Associated With Angiotensin II-Induced Hypertension.

Authors:  Nayaab S Khan; Chi Young Song; Shyamala Thirunavukkarasu; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Am J Hypertens       Date:  2015-06-04       Impact factor: 2.689

Review 4.  Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation.

Authors:  Christian D Sadik; Andrew D Luster
Journal:  J Leukoc Biol       Date:  2011-11-04       Impact factor: 4.962

5.  Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice.

Authors:  Jincun Zhao; Jingxian Zhao; Kevin Legge; Stanley Perlman
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

6.  A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis.

Authors:  Linda Vong; Jose G P Ferraz; Remo Panaccione; Paul L Beck; John L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

7.  Pathogen induced chemo-attractant hepoxilin A3 drives neutrophils, but not eosinophils across epithelial barriers.

Authors:  S A Kubala; S U Patil; W G Shreffler; B P Hurley
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-12-04       Impact factor: 3.072

Review 8.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

9.  Interaction between prostaglandin D and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cells.

Authors:  L Xue; A Barrow; R Pettipher
Journal:  Clin Exp Immunol       Date:  2009-02-11       Impact factor: 4.330

Review 10.  Inflammatory signaling through leukotriene receptors in atherosclerosis.

Authors:  Magnus Bäck
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.